“Without Captivate®, we wouldn’t have been able to afford a compliant EDC platform. Running a 150-plus-participant study on paper just isn’t feasible,” said Caitlin, Head of Research at Myota Health. “The Weidley’s Wish program was truly a game-changer for us.”
Through ClinCapture’s Weidley’s Wish initiative which provides low-cost access to Captivate® for philanthropic, academic, and early-stage organizations Myota implemented Captivate® to manage its latest double-blind, placebo-controlled clinical trial.
Captivate’s® flexible interface enabled Myota’s small team to design study forms, questionnaires, and rules in-house, while ClinCapture’s support team guided them through each phase of setup.
“The Weidley’s Wish program was truly a game-changer for us.”
Even in its early stages, the study has already benefited from Captivate’s® real-time visibility and secure role-based access. The platform allows Myota to audit data quality without accessing sensitive participant information—ensuring regulatory compliance and peace of mind.
Their principal investigator, who typically uses an academic-focused EDC at the university level, praised Captivate’s® usability:
“She said Captivate® was much more user-friendly and visually clear. That kind of feedback says a lot,” Caitlin added.
For Myota, Captivate® has done more than streamline data collection—it has made high-quality research possible.
“Captivate® lets us pursue the cutting-edge science we’re passionate about without breaking our budget,” said Caitlin
Myota plans to continue using Captivate® for future studies across its three core research areas: gut-brain health, metabolic health, and digestive function. The company’s long-term vision is to bridge the gap between scientific discovery and consumer health through validated, evidence-based formulations.
